GeoVax Awarded NIH Grant for Novel Zika Vaccine
24 mai 2018 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, , May 24, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that the National Institute of Allergy and...